186 related articles for article (PubMed ID: 25595223)
21. Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products.
Sun Y; Zhou H; Zhu H; Leung SW
Sci Rep; 2016 Jan; 6():19312. PubMed ID: 26805727
[TBL] [Abstract][Full Text] [Related]
22. Molecular modeling and simulation of FabG, an enzyme involved in the fatty acid pathway of Streptococcus pyogenes.
Shafreen RB; Pandian SK
J Mol Graph Model; 2013 Sep; 45():1-12. PubMed ID: 23988477
[TBL] [Abstract][Full Text] [Related]
23. Discovery of potent inhibitor for matrix metalloproteinase-9 by pharmacophore based modeling and dynamics simulation studies.
Kalva S; Azhagiya Singam ER; Rajapandian V; Saleena LM; Subramanian V
J Mol Graph Model; 2014 Apr; 49():25-37. PubMed ID: 24473069
[TBL] [Abstract][Full Text] [Related]
24. Comparative and pharmacophore model for deacetylase SIRT1.
Huhtiniemi T; Wittekindt C; Laitinen T; Leppänen J; Salminen A; Poso A; Lahtela-Kakkonen M
J Comput Aided Mol Des; 2006 Sep; 20(9):589-99. PubMed ID: 17103016
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening.
Saxena S; Devi PB; Soni V; Yogeeswari P; Sriram D
J Mol Graph Model; 2014 Feb; 47():37-43. PubMed ID: 24316937
[TBL] [Abstract][Full Text] [Related]
27. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.
Gogoi D; Chaliha AK; Sarma D; Kakoti BB; Buragohain AK
Biomed Pharmacother; 2017 Jan; 85():646-657. PubMed ID: 27903422
[TBL] [Abstract][Full Text] [Related]
28. A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling.
Yadav MK; Singh A; Swati D
Appl Biochem Biotechnol; 2014 Aug; 173(8):2174-88. PubMed ID: 24970047
[TBL] [Abstract][Full Text] [Related]
29. Identification of non-resistant ROS-1 inhibitors using structure based pharmacophore analysis.
Pathak D; Chadha N; Silakari O
J Mol Graph Model; 2016 Nov; 70():85-93. PubMed ID: 27693947
[TBL] [Abstract][Full Text] [Related]
30. Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.
Chen KC; Jian YR; Sun MF; Chang TT; Lee CC; Chen CY
J Biomol Struct Dyn; 2013; 31(11):1207-18. PubMed ID: 23075283
[TBL] [Abstract][Full Text] [Related]
31. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
Kurczab R; Bojarski AJ
J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
[TBL] [Abstract][Full Text] [Related]
32. Discovery and mechanism study of SIRT1 activators that promote the deacetylation of fluorophore-labeled substrate.
Wu J; Zhang D; Chen L; Li J; Wang J; Ning C; Yu N; Zhao F; Chen D; Chen X; Chen K; Jiang H; Liu H; Liu D
J Med Chem; 2013 Feb; 56(3):761-80. PubMed ID: 23316803
[TBL] [Abstract][Full Text] [Related]
33. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
Reddy KK; Singh SK
Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
[TBL] [Abstract][Full Text] [Related]
34. Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis.
Kalva S; Saranyah K; Suganya PR; Nisha M; Saleena LM
J Mol Graph Model; 2013 Jul; 44():297-310. PubMed ID: 23938376
[TBL] [Abstract][Full Text] [Related]
35. Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors.
Shih KC; Shiau CW; Chen TS; Ko CH; Lin CL; Lin CY; Hwang CS; Tang CY; Chen WR; Huang JW
Bioorg Med Chem Lett; 2011 Aug; 21(15):4490-7. PubMed ID: 21724393
[TBL] [Abstract][Full Text] [Related]
36. In silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.
Ghaffar A; Batool S; Mushtaq G; Kamal MA
Curr Comput Aided Drug Des; 2017; 13(3):222-233. PubMed ID: 28294049
[TBL] [Abstract][Full Text] [Related]
37. Mounting evidence validates Ursolic Acid directly activates SIRT1: A powerful STAC which mimic endogenous activator of SIRT1.
Bakhtiari N; Mirzaie S; Hemmati R; Moslemee-Jalalvand E; Noori AR; Kazemi J
Arch Biochem Biophys; 2018 Jul; 650():39-48. PubMed ID: 29758202
[TBL] [Abstract][Full Text] [Related]
38. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies.
Reddy KK; Singh SK; Tripathi SK; Selvaraj C
SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430
[TBL] [Abstract][Full Text] [Related]
39. Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors.
Saxena S; Chaudhaery SS; Varshney K; Saxena AK
SAR QSAR Environ Res; 2010 Jul; 21(5-6):445-62. PubMed ID: 20818581
[TBL] [Abstract][Full Text] [Related]
40. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
